Introduction ST-Elevation Myocardial Infarction (STEMI) accounted for 43.3% of Acute Coronary Syndromes (ACS) in Malaysia in 2019. Malaysia uses thrombolysis, specifically streptokinase, for acute STEMI reperfusion, even though Primary Percutaneous Coronary Intervention (PPCI) is the gold standard. This study investigates thrombolysis results and …